670280-13-4 Usage
Uses
Used in Pharmaceutical Industry:
3-(aminomethyl)benzenesulfonamide hydrochloride is used as an antibiotic for its ability to inhibit bacterial growth by disrupting the synthesis of dihydrofolic acid, a crucial component for the production of purines and pyrimidines necessary for bacterial replication.
Used in Diuretic Applications:
In the pharmaceutical industry, 3-(aminomethyl)benzenesulfonamide hydrochloride serves as a diuretic, aiding in the increase of urine output and helping to remove excess water and salts from the body, which can be beneficial in treating conditions like edema and high blood pressure.
Used in Antihypertensive Therapy:
3-(aminomethyl)benzenesulfonamide hydrochloride is utilized as an antihypertensive agent, contributing to the reduction of blood pressure by promoting the excretion of excess fluid and salts, thus helping to manage hypertension effectively.
Check Digit Verification of cas no
The CAS Registry Mumber 670280-13-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,0,2,8 and 0 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 670280-13:
(8*6)+(7*7)+(6*0)+(5*2)+(4*8)+(3*0)+(2*1)+(1*3)=144
144 % 10 = 4
So 670280-13-4 is a valid CAS Registry Number.
670280-13-4Relevant academic research and scientific papers
PRO-DRUG FORMING COMPOUNDS
-
Page/Page column 31, (2015/02/02)
Various prodrug compounds having the general structure: Active agent- (acid)-(linker) - SO2NR1R2 are described herein. Compounds having this general structure were shown to be more orally active than the unmodified parent molecule.
2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
-
Page/Page column 86, (2010/04/03)
Pyrido(3,2-d)pyrimidine derivatives represented by the structural formuia (Ia): wherein, R1, R2 and R3 are defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro
Multicyclic bis-amide MMP inhibitors
-
Page/Page column 86-87, (2008/06/13)
The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.
